Evidence map›Paper›PMID 29330353›Full record

ArticleGenes & development2017

Afadin and RhoA control pancreatic endocrine mass via lumen morphogenesis.

D Berfin Azizoglu, Caitlin Braitsch, Denise K Marciano, Ondine Cleaver

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Dynamics of primary cilia in endothelial and mesenchymal cells throughout mouse lung development.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Article
  4. The dynamics of tubulogenesis in development and disease.Development (Cambridge, England) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Development of the Pancreatic Ducts and Their Contribution to Organogenesis.Advances in anatomy, embryology, and cell biology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Hippo Signaling Pathway in Pancreas Development.Frontiers in cell and developmental biology · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. ROCK-nmMyoII, Notch andDevelopment (Cambridge, England) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D Berfin AzizogluDepartment of Molecular Biology, Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Caitlin BraitschDepartment of Molecular Biology, Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Denise K MarcianoDepartment of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Ondine CleaverDepartment of Molecular Biology, Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
The University of Texas Southwestern Medical Center · US

Funding

Engineering erythropoietin-producing cellsR24DK106743 · NIDDK · ROGOSIN INSTITUTE · PI CARROLL, THOMAS JOSEPH, CLEAVER, ONDINE B · 2015 to 2019
$7.0M
DIVISION OF CELL &MOLECULAR BIOLOGY TRAINING PROGRAMT32GM008203 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1987 to 2018
$7.0M
Role of afadin signaling in nephron tubulogenesisR01DK099478 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MARCIANO, DENISE K · 2014 to 2018
$1.7M
Blood vessel tubulogenesis: Rasip1-directed GTPase signaling and cell polarity.R01HL113498 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI CLEAVER, ONDINE B · 2012 to 2015
$1.7M
Endothelial Signals During OrganogenesisR01DK079862 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI CLEAVER, ONDINE B · 2007 to 2011
$1.5M
NHLBI NIH HHS R01 HL113498NIDDK NIH HHS R01 DK079862NIDDK NIH HHS R01 DK099478NIDDK NIH HHS R24 DK106743NIGMS NIH HHS T32 GM008203
6 · The paper itself

Abstract

Proper lumen morphogenesis during pancreas development is critical to endocrine and exocrine cell fate. Recent studies showed that a central network of lumens (termed core), but not the surrounding terminal branches (termed periphery), produces most islet endocrine cells. To date, it remains unclear how pancreatic lumens form and remodel and which aspects of lumen morphogenesis influence cell fate. Importantly, models testing the function of the central lumen network as an endocrine niche are lacking. Here, we identify mechanisms underlying lumen formation and remodeling and show that central lumen network morphogenesis impacts pancreatic endocrine mass. We show that loss of the scaffolding protein Afadin disrupts de novo lumenogenesis and lumen continuity in the tip epithelium. Codepletion of the actomyosin regulator RhoA and Afadin results in defects in the central lumens and arrests lumen remodeling. This arrest leads to prolonged perdurance of the central lumen network over developmental time and expansion of the endocrine progenitor population and, eventually, endocrine mass. Our study uncovers essential roles of Afadin and RhoA in pancreatic central lumen morphogenesis, which subsequently determines endocrine cell mass.

Indexed as

AnimalsCell DifferentiationCell MembraneEndocrine CellsMiceMicrofilament ProteinsMicroscopy, Electron, TransmissionMorphogenesisMutationPancreasrhoA GTP-Binding Proteinrho GTP-Binding ProteinsafadinMicrofilament ProteinsrhoA GTP-Binding ProteinRhoA protein, mouserho GTP-Binding Proteinsactomyosinapical polarityisletprogenitor nicheRab GTPasesvesicular trafficking

Identifiers

PMID29330353
PMCPMC5795784
OpenAlexW2783480324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.